✦ LIBER ✦

Immunological characterization of type 1 plasminogen activator inhibitor (PAI-1) binding to native and urea-treated vitronectin (VN)

✍ Scribed by S.G. Shaughnessy; T.J. Podor

Book ID: 119154604
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 134 KB
Volume: 8
Category: Article
ISSN: 0268-9499
DOI: 10.1016/0268-9499(94)90575-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Metabolism of type 1 plasminogen activat

Metabolism of type 1 plasminogen activator inhibitor (PAI-1) and vitronectin (VN) in a human megakaryocytic cell line

✍ S.A. Hill; P.L. Joshua; T.J. Podor 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 152 KB

123 Production and characterization of r

123 Production and characterization of recombinant porcine plasminogen activator inhibitor type 1 (PAI-1)

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 126 KB

73 Disruption of vitronectin-mediated bi

73 Disruption of vitronectin-mediated binding of plasminogen activator inhibitor-1 to fibrin stimulates tissue-type plasminogen activator induced fibrinolysis

✍ Thomas J. Podor; Martin Butcher; Denise Foulon; Daniel A. Lawrence; Steingrimur 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Characterization of the Binding of Uroki

Characterization of the Binding of Urokinase-type Plasminogen Activator (u-PA) to Plasminogen, to Plasminogen-activator Inhibitor-1 and to the u-PA Receptor

✍ H. Roger Lijnen; Frans De Cock; Désiré Collen 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 929 KB

Plasminogen activator inhibitor-1 regula

Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin

✍ Gary Deng; Scott A. Curriden; Geng Hu; Ralf-Peter Czekay; David J. Loskutoff 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

## Abstract Plasminogen activator inhibitor‐1 (PAI‐1) binds to the somatomedin B (SMB) domain of vitronectin. It inhibits the adhesion of U937 cells to vitronectin by competing with the urokinase receptor (uPAR; CD87) on these cells for binding to the same domain. Although the inhibitor also blocks

44 Low expression of plasminogen activat

44 Low expression of plasminogen activator inhibitor (PAI) type 1 (PAI1) and high level of PAI type 2 (PAI2) are associated to a better outcome in gliomas

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 135 KB